We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+10.56%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$120B
AUM Growth
+$5B
(+4.4%)
Cap. Flow
-$4.23B
Cap. Flow
% of AUM
-3.53%
Top 10 Holdings %
Top 10 Hldgs %
33.52%
Holding
335
New
4
Increased
58
Reduced
216
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$227M |
| 2 |
GSK
GSK
|
+$68.2M |
| 3 |
Elanco Animal Health
ELAN
|
+$48.2M |
| 4 |
Intel
INTC
|
+$45M |
| 5 |
Capri Holdings
CPRI
|
+$44.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$764M |
| 2 |
Microsoft
MSFT
|
+$272M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$262M |
| 4 |
Caterpillar
CAT
|
+$148M |
| 5 |
Novartis
NVS
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.41% |
| 2 | Technology | 30.05% |
| 3 | Industrials | 12.22% |
| 4 | Consumer Discretionary | 9.43% |
| 5 | Financials | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Xencor
XNCR
$1.55B
| $194M | 0.16% |
7,750,852
+188,033
| +2% | +$5.12M |
|
102
Goldman Sachs
GS
$303B
| $193M | 0.16% |
596,950
-6,700
| -1% | -$2.2M |
|
103
Fidelity National Information Services
FIS
$22.1B
| $190M | 0.16% |
3,469,585
-294,400
| -8% | -$16.2M |
|
104
General Dynamics
GD
$106B
| $188M | 0.16% |
875,820
-27,790
| -3% | -$6M |
|
105
Edwards Lifesciences
EW
$51.7B
| $183M | 0.15% |
1,936,000
| – | – |
|
106
Citigroup
C
$226B
| $179M | 0.15% |
3,884,846
-230,400
| -6% | -$10.8M |
|
|
107
Capri Holdings
CPRI
$1.74B
| $173M | 0.14% |
4,825,828
+1,116,753
| +30% | +$44.3M |
|
108
Mastercard
MA
$493B
| $167M | 0.14% |
424,800
+3,000
| +0.7% | +$1.13M |
|
109
Teradyne
TER
$59.3B
| $164M | 0.14% |
1,469,305
-53,950
| -4% | -$5.41M |
|
110
XPeng
XPEV
$11.6B
| $162M | 0.14% |
12,056,377
-55,500
| -0.5% | -$547K |
|
111
Marriott International
MAR
$92.3B
| $161M | 0.13% |
878,900
-11,246
| -1% | -$1.95M |
|
112
Sysco
SYY
$40.3B
| $157M | 0.13% |
2,112,745
+75,695
| +4% | +$5.6M |
|
113
Nutanix
NTNX
$16.9B
| $154M | 0.13% |
5,505,293
-116,600
| -2% | -$3.1M |
|
114
Otis Worldwide
OTIS
$28.2B
| $151M | 0.13% |
1,699,341
-14,300
| -0.8% | -$1.2M |
|
115
Keysight
KEYS
$58.3B
| $141M | 0.12% |
841,705
-49,580
| -6% | -$7.69M |
|
116
Rhythm Pharmaceuticals
RYTM
$7.96B
| $137M | 0.11% |
8,299,317
+692,006
| +9% | +$12.5M |
|
117
Autodesk
ADSK
$52.6B
| $133M | 0.11% |
650,400
| – | – |
|
118
Xometry
XMTR
$5.34B
| $132M | 0.11% |
6,240,278
+2,028,840
| +48% | +$35.5M |
|
119
Palo Alto Networks
PANW
$297B
| $131M | 0.11% |
1,026,204
-14,480
| -1% | -$1.51M |
|
120
Freeport-McMoran
FCX
$97.5B
| $131M | 0.11% |
3,269,100
+40,900
| +1% | +$1.56M |
|
121
Revvity
RVTY
$12.8B
| $130M | 0.11% |
1,096,535
-57,800
| -5% | -$7.1M |
|
122
Pinterest
PINS
$13.4B
| $129M | 0.11% |
4,735,900
-100
| -0% | -$2.49K |
|
123
Alkermes
ALKS
$8.25B
| $129M | 0.11% |
4,126,240
-72,050
| -2% | -$2.18M |
|
124
Stryker
SYK
$130B
| $128M | 0.11% |
420,100
-44,470
| -10% | -$12.8M |
|
125
Carnival Corporation Ltd
CCL
$39.7B
| $124M | 0.1% |
6,608,578
-40,800
| -0.6% | -$477K |
|
Similar funds
VAM
Primecap Management's Q2 2023 Portfolio in Review
As of Q2 2023, Primecap Management held 335 positions worth $120B, up 4.4% from $115B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Primecap Management withdrew a net $4.23B in Q2 2023, closing 7 positions and reducing 216 holdings. Its most notable exit was Maxar Technologies Inc. Common Stock, an estimated $27M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Industrials.
Against the trend, Primecap Management opened a new position in Sphere Entertainment worth $17.1M.
- Primecap Management's largest Q2 2023 buy was Sphere Entertainment: 623,078 shares worth $17.1M.
- Primecap Management added most to Seagen Inc. Common Stock in Q2 2023, an estimated $227M increase.
- Primecap Management's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $764M.
- Primecap Management fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $27M.
- Primecap Management's ten largest holdings make up 34% of its $120B portfolio in Q2 2023.
- Primecap Management opened 4 new positions and closed 7 in Q2 2023.
- Primecap Management's portfolio value rose 4.4% quarter-over-quarter to $120B.
Based on Primecap Management's 13F filing for Q2 2023, filed 11 Aug 2023.